Particularly, we demonstrated that BRD9 mediates the enrichment of H3K27ac at ENO2 and ALDOC gene loci, thereby enhancing the glycolytic activities of colon cancer cells. This evidence concerns the gene BRD9 and malignant colon neoplasm.